Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities — 017

Great Saphenous Vein Incompetence Clinical Trial

Official title:
A Multicenter, Randomized, Blinded Study of Endovenous Thermal Ablation With or Without Varisolve™ Polidocanol Endovenous Microfoam (PEM) Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities

Status Completed

Clinical Trial Summary

Varicose veins are enlarged, noticeably bulging veins, which commonly occur in the legs and may cause discomfort. In this study, patients with varicose veins in the legs will be participating. The purpose of this research study is to evaluate the safety and effectiveness of two different doses of an investigational drug, Polidocanol Endovenous Microfoam (PEM) compared to vehicle (inactive solution) when used following an approved heat treatment in subjects with varicose veins.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Great Saphenous Vein Incompetence
Varicose Veins
Visible Varicosities

Clinical Trial Details

NCT number	NCT01197833
Study type	Interventional
Source	Boston Scientific Corporation
Contact
Status	Completed
Phase	Phase 3
Start date	September 2010
Completion date	December 2012

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT03946644` - Safety Distance for Endovenous Laser Ablation of the Great Saphenous Vein	N/A